Exploiting ROS and metabolic differences to kill cisplatin resistant lung cancer-Reference-Cited by-同舟云学术

Exploiting ROS and metabolic differences to kill cisplatin resistant lung cancer

Published:2017-05-02 Issue:30 Volume:8 Page:49275-49292
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Wangpaichitr Medhi¹²,Wu Chunjing¹,Li Ying Ying³,Nguyen Dan J.M.⁴,Kandemir Hande⁵,Shah Sumedh⁴,Chen Shumei⁶,Feun Lynn G.³,Prince Jeffrey S.⁴,Kuo Macus T.⁷,Savaraj Niramol¹³

Affiliation:

1. Miami VA Healthcare System, Research Service, Miami, FL, USA

2. Department of Surgery, Cardiothoracic Surgery, University of Miami, Miami, FL, USA

3. Department of Medicine, Hematology/Oncology, University of Miami, Miami, FL, USA

4. Department of Biology, University of Miami, Miami, FL, USA

5. School of Medicine, Koc University, Istanbul, Turkey

6. Department of Neurosurgery, Taipei Medical University-Wan Fang Hospital, Taipei, Taiwan

7. Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cisplatin Resistance and Metabolism: Simplification of Complexity;Cancers;2024-09-04

2. Glutamine-addiction in cisplatin resistant cancer cells is mediated by SLC7A11 and can be targeted with asparaginase therapy;2024-07-22

3. Overcoming Cancer Persister Cells by Stabilizing the ATF4 Promoter G‐quadruplex;Advanced Science;2024-07-12

4. Disulfidptosis-related signature elucidates the prognostic, immunologic, and therapeutic characteristics in ovarian cancer;Frontiers in Genetics;2024-04-17

5. Cisplatin-Resistant Urothelial Bladder Cancer Cells Undergo Metabolic Reprogramming beyond the Warburg Effect;Cancers;2024-04-05